Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Palatin Technologies (PTN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 192,720
  • Shares Outstanding, K 198,680
  • Annual Sales, $ 44,720 K
  • Annual Income, $ -13,330 K
  • 36-Month Beta 1.63
  • Price/Sales 2.40
  • Price/Cash Flow N/A
  • Price/Book 17.98
  • Price/Earnings ttm 7.19
  • Earnings Per Share ttm 0.13
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 09/24/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/18
See More
  • Average Estimate 0.02
  • Number of Estimates 1
  • High Estimate 0.02
  • Low Estimate 0.02
  • Prior Year 0.07
  • Growth Rate Est. (year over year) -71.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.88 +10.23%
on 08/08/18
1.02 -4.90%
on 07/20/18
-0.04 (-3.96%)
since 07/16/18
3-Month
0.87 +11.37%
on 06/19/18
1.28 -24.22%
on 06/04/18
-0.28 (-22.40%)
since 05/16/18
52-Week
0.38 +151.95%
on 08/22/17
1.59 -38.99%
on 04/10/18
+0.57 (+139.51%)
since 08/16/17

Most Recent Stories

More News
Analysis: Positioning to Benefit within FIS, Helix Energy, Palatin Technologies, NiSource, Service Corporation International, and Summit Hotel Properties -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Fidelity National Information...

FIS : 106.34 (+0.30%)
HLX : 8.92 (+0.68%)
SCI : 41.50 (-0.31%)
INN : 13.55 (+0.07%)
PTN : 0.97 (+3.74%)
NI : 27.52 (+1.21%)
Free Pre-Market Technical Recap on TherapeuticsMD and Three Additional Healthcare Stocks

Stock Research Monitor: IDXX, PTN, and ZGNX

IDXX : 243.26 (+0.70%)
PTN : 0.97 (+3.74%)
TXMD : 5.55 (+2.02%)
Palatin Technologies Added to Russell 3000® Index

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need...

PTN : 0.97 (+3.74%)
Stock Performance Review on TherapeuticsMD and Three Other Healthcare Stocks

Stock Research Monitor: IDXX, PTN, and SNY

IDXX : 243.26 (+0.70%)
PTN : 0.97 (+3.74%)
Palatin Technologies Announces FDA Acceptance for Review of Bremelanotide NDA

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical needs...

PTN : 0.97 (+3.74%)
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need...

PTN : 0.97 (+3.74%)
Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018

Palatin Technologies, Inc. (NYSE American: PTN) will announce its third quarter, fiscal year 2018 operating results on Tuesday, May 15, 2018 before the open of the U.S. financial markets.

PTN : 0.97 (+3.74%)
Factors of Influence in 2018, Key Indicators and Opportunity within American Homes 4 Rent, Discovery Communications, Vertex Pharmaceuticals, The New York Times, Palatin Technologies, and E*TRADE Financial -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of American Homes 4 Rent (NYSE:AMH),...

DISCK : 24.49 (+1.07%)
VRTX : 174.96 (+1.13%)
NYT : 23.15 (+0.43%)
PTN : 0.97 (+3.74%)
AMH : 22.81 (+0.71%)
ETFC : 61.29 (+1.59%)
Palatin Technologies Presents Positive Preclinical MC1 Receptor Agonist Data at TIDES: Oligonucleotide and Peptide Therapeutics 2018 Meeting in Boston, Massachusetts

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical needs...

PTN : 0.97 (+3.74%)
Pre-Market Technical Scan on Healthcare Equities -- Atossa Genetics, Palatin Technologies, Quotient, and Avadel Pharma

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on ATOS, PTN, QTNT, and AVDL which can be accessed for free by signing up to www.wallstequities.com/registration....

AVDL : 4.77 (-2.45%)
ATOS : 2.31 (+6.45%)
PTN : 0.97 (+3.74%)
QTNT : 7.33 (+1.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade PTN with:

Business Summary

Palatin Technologies, Inc is a development-stage medical technology companyinvolved in developing and commercializing products and technologies fordiagnostic imaging, cancer therapy and ethical drug development These developments are based on its proprietary monoclonal antibody radiolabeling and enabling...

See More

Key Turning Points

2nd Resistance Point 1.00
1st Resistance Point 0.99
Last Price 0.97
1st Support Level 0.94
2nd Support Level 0.91

See More

52-Week High 1.59
Fibonacci 61.8% 1.13
Fibonacci 50% 0.99
Last Price 0.97
Fibonacci 38.2% 0.85
52-Week Low 0.38

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar